Skip to content
OpenCapital
Get started

BioMarin Pharmaceuticals BMRN Products Excluding Product One — Revenue

Discontinued — last reported Q4 '22

Similar metrics at other companies

Biogen logo
BIIBOther corporate revenues — Product revenues
$114.2M-20.6%
Incyte logo
INCYProduct And Service Other — Revenue
$58K+105%
Exelixis logo
EXELNet product revenues — Total revenues
$554.98M+8.1%
Illumina logo
ILMNOther Products — Revenue
$6M+14.3%
Biogen logo
BIIBRare Disease Product Revenue — Total Revenue
$557.2M-1.1%
Biogen logo
BIIBProduct revenue, net — Total Revenue
$1.75B+1.5%

Other financials

Income statement

See full
Revenue$766.2M+2.8%
Gross profit$571.2M-3.8%
Operating income$129.6M-42.1%
Net income$105.5M-43.2%
EPS (diluted)$0.54-43.2%

Balance sheet

See full
Cash & equivalents$3.1B+193%
Total debt$1.4B+138%
Total equity$6.2B+7.2%
Total assets$8.6B+20.2%

Cash flow

See full
Operating cash flow$220.7M+26.5%
CapEx$20.9M+24.8%
Free cash flow$199.7M+26.7%

Valuation

See full
Market cap$10.57B-19.4%
Enterprise value$8.93B-29.3%
P/E21.1×-22.7×
P/S3.3×-1.2×

Profitability

See full
Gross margin76.5%-2.9pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin23.7%+2.5pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.2×+0.1×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by BioMarin Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: BioMarin Pharmaceuticals’s 10-K, filed February 27, 2023, on SEC EDGAR. View the filing →

Ask your AI about BioMarin Pharmaceuticals's products excluding product one — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioMarin Pharmaceuticals's products excluding product one — revenue?
BioMarin Pharmaceuticals (BMRN) reported products excluding product one — revenue of $487.83M in Q4 2022.
How has BioMarin Pharmaceuticals's products excluding product one — revenue changed year-over-year?
BioMarin Pharmaceuticals's products excluding product one — revenue increased by 17.6% year-over-year, from $414.97M to $487.83M.
What does products excluding product one — revenue mean?
The total revenue generated by all company products except for the single largest revenue-producing product.
How do you interpret products excluding product one — revenue?
An increase indicates successful commercial scaling and market adoption of the company's secondary therapeutic assets, reducing dependency on a single product. A decrease may suggest market saturation, increased competition, or declining demand within the non-core product portfolio.
How does products excluding product one — revenue compare across companies?
Similar to 'non-core product revenue' or 'revenue excluding top-selling drug' metrics used by other specialty pharmaceutical and biotechnology firms to demonstrate portfolio diversification.